Uncategorised - European Medical Journal

Tool Accurately Detects Risk of Asthma in Young Children

Researchers have developed a tool allowing for the detection of asthma risk in children as young as 2 years old…

EMJ

Infographic: Improving Outcomes in Haemodialysis: A New Look at an Old Issue

This infographic explores a contemporary strategy to decrease the risk of cardiovascular disease and mortality associated with end-stage kidney disease (ESKD).

Renal Disease Risk: Direct Oral Anticoagulants Versus Vitamin K Antagonists

New research shows that using DOAC for the treatment of atrial fibrillation could reduce the risk of CKD progression.

Does Ethnicity Impact Hospitalisation Rates in Patients with Advanced Kidney Disease?

Ethnicity could play a role in hospitalisation outcomes for patients with advanced kidney disease. Read now to find out more.

Optimising Antimicrobial Stewardship to Tackle Clostridioides difficile Infection and Improve Patient Outcomes

Clostridioides difficile, formerly known as Clostridium difficile, is a Gram-positive spore-forming and toxin-producing bacterium that causes diarrhoea in vulnerable patient groups. It is a common hospital-acquired infection but also occurs in the community.

Precision Medicine in Prostate Cancer – Interview with Henrik Grönberg

Focusing on the topic of precision medicine in prostate cancer, this podcast offers valuable insights into the impact that its widespread…

New Frontiers in Chronic Obstructive Pulmonary Disease: Where Are We Heading?

All human diseases, including COPD, are the end result of gene–environment interactions.1 However, this conventional model is being modified. COVID-19 demonstrated that mortality is higher in older versus younger individuals. The viral and environmental exposures were the same, but the obvious difference was age.

Creating winning pharma communications

Silvia Taylor, Executive Vice President and Chief Communications Officer, Novavax, discusses her passion for engaging the world in the wonder of science.

Infographic: Systemic mastocytosis (SM) is a rare form of mast cell disorder characterised by abnormal proliferation and activation of mast cells

Systemic Mastocytosis Disease Awareness Infographic: Learn more about this rare disease, its prevelance, symptoms, sub-types and diagnosis.

Review of the United European Gastroenterology (UEG) Week 2022

‘INGEST the best’ was the theme for the 30th anniversary of the United European Gastroenterology (UEG) Week, which took place in Vienna, Austria, and virtually on 8th–11th October 2022.